FDA Adverse Event Injury Summary report: N

NEUROFORM STENT

MDR report key: 1952916 · Received January 7, 2011

Report

Report Number
2939204-2010-01166
Event Type
Injury
Date Received
January 7, 2011
Date of Event
December 14, 2010
Report Date
December 14, 2010
Manufacturer
BOSTON SCIENTIFIC - FREMONT
Product Code
NJE
PMA / PMN Number
H020002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

CONCLUSION: ANTICIPATED PROCEDURAL COMPLICATION. A DEVICE HISTORY RECORD REVIEW CONFIRMED THAT THE DEVICE ALL MET MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE DEVICE WAS RETURNED WITH THE GUIDEWIRE USED IN THE PROCEDURE. INSPECTION OF THE MICRODELIVERY CATHETER NOTED THAT IT WAS SLIGHTLY COMPRESSED 6CM FROM THE DISTAL END. INSPECTION OF THE STABILIZER NOTED THAT IT WAS BENT ON ITS PROXIMAL SHAFT. THE STENT WAS IN THE MICRODELIVERY CATHETER WITH THE STABILIZER BUTTED UP AGAINST ITS PROXIMAL END, IT WAS DEPLOYED ON THE TABLE AND NO ANOMALIES WERE NOTED. NO ANOMALIES WERE NOTED TO THE DEVICE THAT COULD HAVE CAUSED OR CONTRIBUTED TO THE REPORTED VESSEL RUPTURE AND INTRACRANIAL HEMORRHAGE. VESSEL RUPTURE AND HEMORRHAGE ARE KNOWN AND ANTICIPATED COMPLICATIONS TO THESE TYPES OF PROCEDURES AND ARE LISTED AS SUCH IN THE DIRECTIONS FOR USE. THEREFORE IT WAS DETERMINED THAT THE REPORTED EVENT WAS AN ANTICIPATED PROCEDURAL COMPLICATION.

Description of Event or Problem · 1

IT WAS REPORTED DURING THE MANIPULATION OF THE DEVICES THE POSTERIOR COMMUNICATING ARTERY RUPTURED. PROTAMINE WAS GIVEN, DOSE WAS NOT DISCLOSED, TO REVERSE THE ANTI-COAGULATION IN RESPONSE TO THE RUPTURE AND THE PATIENT SUFFERED AN INTRACRANIAL HEMORRHAGE. THE PATIENT WAS REPORTED TO BE "NOT DOING WELL" IMMEDIATELY AFTER THE EVENT AND NO OTHER INFORMATION WAS PROVIDED AS TO THE CURRENT CONDITION OF THE PATIENT.

Description of Event or Problem · 1

IT WAS REPORTED DURING THE MANIPULATION OF THE DEVICES THE POSTERIOR COMMUNICATING ARTERY RUPTURED. PROTAMINE WAS GIVEN, DOSE WAS NOT DISCLOSED, TO REVERSE THE ANTI-COAGULATION IN RESPONSE TO THE RUPTURE AND THE PATIENT SUFFERED AN INTRACRANIAL HEMORRHAGE. THE PATIENT WAS REPORTED TO BE "NOT DOING WELL" IMMEDIATELY AFTER THE EVENT AND NO OTHER INFORMATION WAS PROVIDED AS TO THE CURRENT CONDITION OF THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 NEUROFORM STENT STENT, INTRACRANIAL NEUROVASCULAR NJE BOSTON SCIENTIFIC - FREMONT M003SNF340200 13630140

Patients

Seq Age Sex Outcome Treatment
1 69 YR Required Intervention SYNCHRO GUIDEWIRE (BOSTON SCIENTIFIC)